全文获取类型
收费全文 | 5214篇 |
免费 | 452篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 102篇 |
妇产科学 | 142篇 |
基础医学 | 943篇 |
口腔科学 | 104篇 |
临床医学 | 524篇 |
内科学 | 965篇 |
皮肤病学 | 184篇 |
神经病学 | 783篇 |
特种医学 | 196篇 |
外科学 | 488篇 |
综合类 | 44篇 |
一般理论 | 4篇 |
预防医学 | 348篇 |
眼科学 | 138篇 |
药学 | 273篇 |
中国医学 | 8篇 |
肿瘤学 | 396篇 |
出版年
2024年 | 21篇 |
2023年 | 104篇 |
2022年 | 161篇 |
2021年 | 240篇 |
2020年 | 169篇 |
2019年 | 218篇 |
2018年 | 245篇 |
2017年 | 193篇 |
2016年 | 251篇 |
2015年 | 252篇 |
2014年 | 280篇 |
2013年 | 319篇 |
2012年 | 505篇 |
2011年 | 481篇 |
2010年 | 239篇 |
2009年 | 219篇 |
2008年 | 312篇 |
2007年 | 258篇 |
2006年 | 262篇 |
2005年 | 239篇 |
2004年 | 168篇 |
2003年 | 183篇 |
2002年 | 136篇 |
2001年 | 16篇 |
2000年 | 12篇 |
1999年 | 14篇 |
1998年 | 26篇 |
1997年 | 23篇 |
1996年 | 17篇 |
1995年 | 11篇 |
1994年 | 14篇 |
1993年 | 5篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1988年 | 3篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1983年 | 4篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1976年 | 2篇 |
1972年 | 2篇 |
1964年 | 2篇 |
1962年 | 2篇 |
1961年 | 2篇 |
1933年 | 4篇 |
1931年 | 2篇 |
1926年 | 5篇 |
排序方式: 共有5675条查询结果,搜索用时 31 毫秒
61.
62.
63.
Katharina Laus Pooja Louis Laura Douglass 《Journal of minimally invasive gynecology》2019,26(1):178-181
Cornual, interstitial, and angular pregnancies are terms that are often used interchangeably in both the literature and clinical setting to describe various ectopic pregnancies. The diagnosis of these pregnancies can be difficult, and fear of disrupting an intrauterine pregnancy can cause hesitation during evaluation and management. In our 2 cases, a combination of transvaginal and 3-dimensional ultrasound images provided assistance in the accurate diagnosis of angular ectopic pregnancies. Traditional management of these pregnancies includes a wedge resection for pregnancy resolution. In this set of 2 cases, we describe a unique surgical approach to resolve these pregnancies using operative hysteroscopy. 相似文献
64.
65.
66.
Health promotion (HP) amongst older people is an increasingly prominent policy concern for governments. The development of an evidence-base and the advocacy of effective interventions in the light of this act as legitimation tools for the overall HP phenomenon – assisting the growth of state and non-state funding for public health initiatives for older people. In structuring decision-making as to which individual projects/initiatives receive funding, frameworks for acknowledging efficacy impact on formats of HP work both positively and negatively. Drawing on recent research across the EU and focusing on the specific national contexts of Austria and England, this comparative policy analysis triangulates best-practice modelling, evaluation data and interviews with project coordinators to explore how policy contexts impact on the nature and format of HP interventions. Amidst a developing awareness of what effective practice looks like, successful HP initiatives must advocate their legitimacy within narrow rules of quality, where measurable outcomes have become the keys which unlock financial resources. Findings across both countries suggest that this instrumentalisation of legitimation, driven by economic pressures and bureaucratic generalisability, threatens the rationality of HP. From a Habermasian perspective, tensions emerge between projects’ remaining reflexive towards processes and their need to articulate the ‘success’ of the interventions in a language of outcomes. Over time, in an era where resources are increasingly scarce and competition over these intensifies, a danger exists whereby the instrumentality of HP begins to separate from, and impinge upon, the capacity for projects to think and act holistically. 相似文献
67.
Katharine Bray-French Katharina Hartman Guido Steiner Céline Marban-Doran Juliana Bessa Neil Campbell Meret Martin-Facklam Kay-Gunnar Stubenrauch Corinne Solier Thomas Singer Axel Ducret 《Journal of pharmaceutical sciences》2021,110(7):2575-2584
Biotherapeutics have revolutionized our ability to treat life-threatening diseases. Despite clinical success, the use of biotherapeutics has sometimes been limited by the immune response mounted against them in the form of anti-drug antibodies (ADAs). The multifactorial nature of immunogenicity has prevented a standardized approach for assessing this and each of the assessment methods developed so far does not exhibit high enough reliability to be used alone, due to limited predictiveness. This prompted the Roche Pharma Research and Early Development (pRED) Immunogenicity Working Group to establish an internal preclinical immunogenicity toolbox of in vitro/in vivo approaches and accompanying guidelines for a harmonized assessment and management of immunogenicity in early development. In this article, the complex factors influencing immunogenicity and their associated clinical ramifications are discussed to highlight the importance of an end-to-end approach conducted from lead optimization to clinical candidate selection. We then examine the impact of the resulting lead candidate categorization on the design and implementation of a multi-tiered ADA/immunogenicity assay strategy prior to phase I (entry into human) through early clinical development. Ultimately, the Immunogenicity Toolbox ensures that Roche pRED teams are equipped to address immunogenicity in a standardized manner, paving the way for lifesaving products with improved safety and efficacy. 相似文献
68.
69.
70.
Michael Dörks Katharina Allers Falk Hoffmann 《Journal of the American Medical Directors Association》2019,20(3):287-293.e7